Alder Biopharmaceuticals Inc. appointed Robert Azelby as president, CEO and director, effective June 13.
Azelby previously served at Juno Therapeutics Inc. as executive vice president and chief commercial officer.
Bothell, Wash.-based Alder is a clinical-stage biopharmaceutical company that discovers, develops and commercializes therapeutic antibodies.
